Abreos Biosciences Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $6.83M
Latest Deal Amount
  • Investors
  • 8

Abreos Biosciences General Information

Description

Developer of lateral flow assays platform that measures the activity of value biologics designed to offer a significant variation in how patients process biologic drugs. The company's platform are laboratory-based and point-of-care assays that enable precision dosing and counterfeit detection of biologic drugs as well as permits for direct monitoring of blood concentrations of monoclonal antibody drugs for dosage, enabling health care industry to get customizable assay for improve outcome.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
  • 2223 Avenida de la Playa
  • Suite 206
  • La Jolla, CA 92037
  • United States
+1 (858) 000-0000

Abreos Biosciences Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abreos Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 15-Sep-2020 $6.83M 00.000 Completed Generating Revenue
6. Grant 25-Feb-2020 00.000 00.000 Completed Generating Revenue
5. Seed Round 29-Mar-2016 000 Cancelled Generating Revenue
4. Seed Round 28-Jun-2016 00.000 00.000 Completed Generating Revenue
3. Grant 25-Sep-2015 00.000 Completed Generating Revenue
2. Grant 23-Sep-2014 $371K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2014 Completed Generating Revenue
To view Abreos Biosciences’s complete valuation and funding history, request access »

Abreos Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of lateral flow assays platform that measures the activity of value biologics designed to offer a significant
Drug Delivery
La Jolla, CA
6 As of 2020
00.000
000000000 00.000

0000000

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepte
0000 00000000
San Francisco, CA
0 As of 0000
000 0000-00-00
000000&0

00000000

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
0000 000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abreos Biosciences Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Trianni Formerly Accelerator/Incubator backed San Francisco, CA 0 000000&0
00000000 000000000 Venture Capital-Backed San Diego, CA 00 00000 0000000000 0 00000
00000 0000000 0000 Corporation San Diego, CA 0
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
0000000000 0000000 Corporate Backed or Acquired Exton, PA 000 000000&0
You’re viewing 5 of 12 competitors. Get the full list »

Abreos Biosciences Executive Team (8)

Name Title Board Seat Contact Info
Bradley Messmer Ph.D Co-Founder, Chief Executive Officer, President & Board Member
William Yashar Director, Business Development
Reed McCalmon Director of Finance
Michael Williams Board Advisor
You’re viewing 4 of 8 executive team members. Get the full list »

Abreos Biosciences Board Members (3)

Name Representing Role Since
Bradley Messmer Ph.D Abreos Biosciences Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Neil Senturia Blackbird Ventures (La Jolla) Executive Chairman & Advisor 000 0000
To view Abreos Biosciences’s complete board members history, request access »

Abreos Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abreos Biosciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TLP Other Minority 000 0000 000000 0
TransMontaigne Partners PE-Backed Company Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Blackbird Ventures (La Jolla) Venture Capital Minority 000 0000 000000 0
Keshif Ventures Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Abreos Biosciences Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 27-Nov-2019 00000 0000000 Monitoring Equipment
To view Abreos Biosciences’s complete investments history, request access »